「Parthipan M, Feng G, Breunis H, Timilshina N, Emmenegger U, Hansen A, Tomlinson G, Matthew A, Clarke H, Santa Mina D, Soto-Perez-de-Celis E, Puts M, Alibhai SMH. Understanding the incidence, duration, and severity of symptoms through daily symptom monitoring among frail and non-frail older patients receiving metastatic prostate cancer treatments. J Geriatr Oncol. 2024 Feb 12;15(3):101720. doi: 10.1016/j.jgo.2024.101720」。
Parthipan M, et al. Understanding the incidence, duration, and severity of symptoms through daily symptom monitoring among frail and non-frail older patients receiving metastatic prostate cancer treatments. J Geriatr Oncol. 2024 Feb 12;15(3):101720. doi: 10.1016/j.jgo.2024.101720
Parthipan M, et al. Understanding the incidence, duration, and severity of symptoms through daily symptom monitoring among frail and non-frail older patients receiving metastatic prostate cancer treatments. J Geriatr Oncol. 2024 Feb 12;15(3):101720. doi: 10.1016/j.jgo.2024.101720
Parthipan M, et al. Understanding the incidence, duration, and severity of symptoms through daily symptom monitoring among frail and non-frail older patients receiving metastatic prostate cancer treatments. J Geriatr Oncol. 2024 Feb 12;15(3):101720. doi: 10.1016/j.jgo.2024.101720
Parthipan M, et al. Understanding the incidence, duration, and severity of symptoms through daily symptom monitoring among frail and non-frail older patients receiving metastatic prostate cancer treatments. J Geriatr Oncol. 2024 Feb 12;15(3):101720. doi: 10.1016/j.jgo.2024.101720
最近のコメント